<DOC>
	<DOCNO>NCT02182141</DOCNO>
	<brief_summary>Maximum tolerate dose ( MTD ) , safety , pharmacokinetics , efficacy BIBF 1120 , pharmacodynamics</brief_summary>
	<brief_title>An Dose Escalation Study BIBF 1120 Administered Patients With Relapsed Refractory Multiple Myeloma</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Nintedanib</mesh_term>
	<criteria>1 . Patients confirm diagnosis multiple myeloma , respond relapse either anthracyclines pulse glucocorticoid highdose therapy currently eligible transplant modality . 2 . Age 18 year old 3 . Life expectancy least six month 4 . Patients give write informed consent ( must consistent ICHGCP local legislation ) 5 . Eastern Cooperative Oncology Group ( ECOG ) performance score &lt; 2 . 6 . Recovery therapyrelated toxicity previous chemo , immuno radiotherapy . 1 . History relevant surgical procedure last four week prior treatment trial drug , active ulcer , fracture injury incomplete heal 2 . Active infectious disease 3 . Uncontrolled , severe hypertension 4 . Gastrointestinal disorder anticipate interfere resorption study drug 5 . Serious illness concomitant nononcological disease consider investigator incompatible protocol 6 . Absolute neutrophil count less 1000 / mm³ . 7 . Platelet count less 30 000 / mm³ 8 . Conjugated Bilirubin great 2 mg / dl ( &gt; 34 μmol/L , SI unit equivalent ) 9 . Aspartate amino transferase ( AST ) / alanine amino transferase ( ALT ) great three time upper limit normal 10 . Endogenous creatinine clearance ( ECC ) &lt; 20 ml/min 11 . Women men sexually active unwilling use medically acceptable method contraception 12 . Pregnancy breastfeed 13 . Treatment investigational drug participation another clinical trial within past four week start therapy concomitantly trial ( except present trial drug ) 14 . Patients unable comply protocol 15 . Active alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>